Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar 1:10:1135178.
doi: 10.3389/fmed.2023.1135178. eCollection 2023.

Case report: Acinetobacter baumannii septic arthritis in an immunocompetent infant

Affiliations
Case Reports

Case report: Acinetobacter baumannii septic arthritis in an immunocompetent infant

Yi Liao et al. Front Med (Lausanne). .

Abstract

Acinetobacter baumannii is a gram-negative coccobacilli, mainly causing nosocomial infections with poor prognosis, especially in patients with prolonged hospitalization or antibiotics administration. A. baumannii pneumonia is the most common clinical form and usually occurs in critically ill patients in the intensive care unit. However, septic arthritis caused by A. baumannii is rarely reported. In this report, we describe a case of A. baumannii septic arthritis combined with incomplete Kawasaki disease in an infant. The child's chief complaint was a 2-week intermittent fever with poor response to antibiotics. Initial physical examination revealed swollen lymph nodes in the neck, pharynx congestion, and the appearance of rashes. Combined with laboratory tests, the diagnosis of incomplete Kawasaki disease was considered. After administration of high-dose intravenous immunoglobulin and corticosteroids, the child's fever improved and periungual desquamation appeared simultaneously. Swelling of the right knee occurred 5 days after the fever improved and imaging tests of MRI and ultrasound suggested the existence of infection. A diagnosis of septic arthritis was established subsequently, and arthroscopy was carried out. A. baumannii was finally identified by metagenomics next-generation sequencing of joint draining fluid for pathogenic microorganisms. Treatment with meropenem was then started. The patient eventually recovered and was discharged from the hospital after 23 days of treatment with meropenem. Although A. baumannii is not a common bacterium of septic arthritis, this rare infection can still occur in infants. Early diagnosis, pathogenic identification, and target antibiotic treatment are important to reduce the occurrence of joint sequelae.

Keywords: Acinetobacter baumannii; case report; infant; metagenomics next-generation sequencing; septic arthritis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
MRI of the right knee [proton density-weighted (A) and T2-weighted (B, C)]. (A) Edema of the anterior cruciate ligament (arrow). (B) Soft tissue around the lower segment of the femur was swollen (arrow). Arrowheads from left to right show abnormal signals in the patella, epiphysis of the femur, and epiphysis of the tibia successively, which may have been caused by infectious disease. (C) Massive effusion is observed in the suprapatellar capsule (left arrow) and joint cavity (right arrow).
Figure 2
Figure 2
(A) Ultrasound of the right knee. An anechoic zone with an anteroposterior diameter of 8.6 mm is seen in the suprapatellar capsule of the joint suggesting effusion in the suprapatellar bursa. (B) X-ray of the right knee in a half-year follow-up of the patient after discharge. No obvious abnormality is found.
Figure 3
Figure 3
A timeline with relevant data from the patient's episode of care. WBC, white blood cell; CRP, C-reactive protein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; IVIG, intravenous immunoglobulin; ESR, erythrocyte sedimentation rate; EBV, Epstein-Barr virus; mNGS, metagenomics next-generation sequencing.

Similar articles

Cited by

References

    1. Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, et al. . Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. (2017) 7:55. 10.3389/fcimb.2017.00055 - DOI - PMC - PubMed
    1. Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. (2021) 48:6987–98. 10.1007/s11033-021-06690-6 - DOI - PMC - PubMed
    1. Liu X, Zhou H, Shu S, Li G, Fang F. Successful treatment with tigecycline of severe pandrug-resistant Acinetobacter baumannii pneumonia complicated with a diaphragmatic hernia: a case report. Ann. Palliat Med. (2022) 12:193–9. 10.21037/apm-22-900 - DOI - PubMed
    1. Nasr P. Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii. J Hosp Infect. (2020) 104:4–11. 10.1016/j.jhin.2019.09.021 - DOI - PubMed
    1. Garnacho-Montero J, Timsit JF. Managing Acinetobacter baumannii infections. Curr Opin Infect Dis. (2019) 32:69–76. 10.1097/QCO.0000000000000518 - DOI - PubMed

Publication types

LinkOut - more resources